Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

June 27th, 2011

Cook Pharmica Executives to Speak at 2011 BIO® International Convention

June 27, 2011

Washington, DC — Two Cook Pharmica executives will speak this week at the 2011 BIO International Convention: The Global Event for Biotechnology held June 27-30 in Washington, D.C. Ryan Hawkins and E. Morrey Atkinson will discuss two increasingly important areas of biopharmaceutical manufacturing.

Hawkins will discuss key considerations in the design and delivery of a modern fill-finish facility. His case study will be based on his experience in leading the design, delivery and operation or Cook Pharmica’s state-of-the art fill-finish facility, which has been featured recently in Pharmaceutical Processing, Drug Development & Delivery, GEN and Pharmaceutical Technology. Atkinson’s presentation will identify key factors biopharmaceutical companies need to know about subvisible particles. Atkinson recently joined Cook Pharmica after leading biotechnology manufacturing sciences and technology for Eli Lilly and Company in Ireland.

Tuesday, June 28th

Who: Ryan Hawkins, Vice President of Drug Product Operations,
Cook Pharmica

What: Design and Delivery of Today’s Fill-Finish Facility

When: 1:20 – 1:45 p.m.

Where: BioProcess Theater in the BioProcess Zone
Hall A, Booth #1563

Wednesday, June 29th

Who: E. Morrey Atkinson, Vice President of Research and Development,
Chief Scientific Officer, Cook Pharmica

What: What You Need to Know About Subvisible Particles in Biotechnology Drugs

When: 11 – 11:20 a.m.

Where: GEN Discovery Theater in the Contract Services Zone
Hall C, Booth #4243
Visit Cook Pharmica at booth #1737 in the BioProcess Zone. If you are unable to attend in person, follow conference activity on Twitter at #bio2011.

About Cook Pharmica
Cook Pharmica is a biopharmaceutical contract development and manufacturing organization (CDMO) with process development, clinical and commercial bulk drug substance manufacturing, formulation development, clinical and commercial parenteral drug product manufacturing including liquid and lyophilized vials, prefilled syringes and secondary packaging, and an array of support services, all at a single facility in Bloomington, Ind. Founded in 2004, Cook Pharmica is a division of Cook Medical, the world’s largest privately held medical manufacturing company.

About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs, cell therapy and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit Follow Cook Medical on Twitter @cookmedicalpr.